Oncologia

Revisão | Tumor de Wilms.

19 Out, 2021 | 12:31h

Wilms tumour – Nature Reviews Disease Primers (gratuito por tempo limitado)

Infográfico: Wilms tumour

 

Comentário no Twitter

This is a schematic showing the timeline of key advances that established the modern clinical management of children with #Wilms tumour https://t.co/lT9ECVeuiZ pic.twitter.com/7KbMSo7qY3

— Nature Reviews Disease Primers (@DiseasePrimers) October 15, 2021

 

---

Trastuzumabe para câncer de mama em estágio inicial e HER-2-positivo: uma metanálise de 13.864 mulheres em 7 estudos randomizados.

15 Out, 2021 | 16:18h

Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13864 women in seven randomised trials – The Lancet Oncology

 

Comentário no Twitter

@OncoAlert Success of a monoclonal antibody when @ right target – 10 yr benefits of trastuzumab – #EBCTCG meta-analysis (N>13,000):
👉Impressive absolute and relative ~1/3 reduced deaths, ~1/3 recurrences
👉ER-: Recur⬇️ 11%
👉ER+: Recur⬇️ 8%@kevinpunie @prat_aleix @itsnot_pink https://t.co/O1WKcEEuGG

— Nicole Kuderer (@NicoleKuderer) August 4, 2021

 

---

Revisão sistemática | Anticoagulantes orais diretos (DOACs) podem ser benéficos para pessoas em tratamento de câncer que não têm indicação terapêutica ou profilática de anticoagulação.

14 Out, 2021 | 10:35h

Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation – Cochrane Library

---

Revisão sistemática | Intervenções musicais podem ter efeitos benéficos sobre ansiedade, depressão, esperança, dor e fadiga em adultos com câncer.

14 Out, 2021 | 10:33h

Music interventions for improving psychological and physical outcomes in people with cancer – Cochrane Library

---

Estudo randomizado | Entre pacientes com câncer colorretal metastático, os randomizados para tratamento sistêmico isolado tiveram menor mortalidade em 60 dias do que aqueles randomizados para ressecção de tumor primário seguida de tratamento sistêmico.

13 Out, 2021 | 12:35h

Sixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment: The CAIRO4 Phase 3 Randomized Clinical Trial – JAMA Surgery (gratuito por tempo limitado)

Editorial: Primary Tumor Resection and Patients With Asymptomatic Colorectal Cancer and Nonresectable Metastases: Results of Recent Randomized Trials – JAMA Surgery (gratuito por tempo limitado)

Comentário: Systemic Therapy Alone Bests Surgical Tx for Metastatic CRC – BreakingMed

 

Comentário no Twitter

Early mortality in patients with colorectal cancer and unresectable metastases randomized to primary tumor resection followed by systemic treatment is considerably higher than early mortality in patients randomized to systemic treatment only https://t.co/SyfYjmDU7i @DaveKruijssen

— JAMA Surgery (@JAMASurgery) October 11, 2021

 

---

Posicionamento científico sobre a ablação percutânea do câncer pulmonar de células não pequenas e doenças metastáticas para os pulmões.

8 Out, 2021 | 12:15h

Society of Interventional Radiology Multidisciplinary Position Statement on Percutaneous Ablation of Non-small Cell Lung Cancer and Metastatic Disease to the Lungs – Journal of Vascular and Interventional Radiology

Comentário: Society of Interventional Radiology issues guidance for minimally invasive lung cancer treatments – Health Imaging

---

Retirada de prescrições de medicamentos em pacientes paliativos com câncer: revisão concisa de ferramentas e diretrizes.

8 Out, 2021 | 12:10h

Deprescribing in palliative patients with cancer: a concise review of tools and guidelines – Supportive Care in Cancer

---

Nefrotoxicidade dos medicamentos para tratamento de câncer: foco nos novos agentes.

8 Out, 2021 | 11:33h

Nephrotoxicity of cancer therapeutic drugs: Focusing on novel agents – Kidney Research and Clinical Practice

---

Estudo de coorte | Efeitos dos lockdowns ocorridos na pandemia de COVID-19 sobre as cirurgias oncológicas eletivas para 15 tipos de tumores em 61 países.

8 Out, 2021 | 11:25h

Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study – The Lancet Oncology

 

Comentário no Twitter (fio – clique para saber mais)

What were the unintended consequences of COVID lockdowns on cancer care?@CovidSurg study in @TheLancetOncol:
🔹Lockdowns independently associated with delayed treatment
🔹At median 5.3 months f/u, 1 in 7 pts had not had planned cancer surgery

🆓https://t.co/UZe0euq5kg pic.twitter.com/4fPl6UEb9D

— Dmitri Nepogodiev (@dnepo) October 5, 2021

 

---

Estudo randomizado SILENCE | Em pacientes em fim de vida, o butilbrometo de escopolamina subcutâneo profilático reduz a ocorrência de estertor da morte (respiração ruidosa causada pelo muco presente no trato respiratório superior).

8 Out, 2021 | 11:12h

Effect of Prophylactic Subcutaneous Scopolamine Butylbromide on Death Rattle in Patients at the End of LifeThe SILENCE Randomized Clinical Trial – JAMA (gratuito por tempo limitado)

Editorial: Preventing Death Rattle With Prophylactic Subcutaneous Scopolamine Butylbromide – JAMA (gratuito por tempo limitado)

Entrevista com os autores: Scopolamine Butylbromide for Preventing End-of-Life Death Rattle – JAMA

 

Comentário no Twitter

In a randomized clinical trial among patients near the end of life, prophylactic subcutaneous scopolamine butylbromide significantly reduced the occurrence of death rattle https://t.co/e6BDI5yirY pic.twitter.com/hHfhC2iYHh

— JAMA (@JAMA_current) October 5, 2021

 

---